We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$2.65B
AUM Growth
+$265M
(+11%)
Cap. Flow
+$82.9M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
21.22%
Holding
487
New
33
Increased
237
Reduced
139
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MUDS
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
|
+$10.3M |
| 2 |
Shoals Technologies Group
SHLS
|
+$6.57M |
| 3 |
Array Technologies
ARRY
|
+$5.42M |
| 4 |
Guardant Health
GH
|
+$4.63M |
| 5 |
BSCP
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
|
+$4.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSCL
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
|
+$7.42M |
| 2 |
Carvana
CVNA
|
+$6.06M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$3.47M |
| 4 |
Beyond Meat
BYND
|
+$3.14M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$2.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 13.39% |
| 3 | Healthcare | 10.89% |
| 4 | Industrials | 9.73% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
SPDR Gold Trust
GLD
$142B
| $610K | 0.02% |
3,685
+832
| +29% | +$141K |
|
|
PPL
302
PPL Corp
PPL
$26.8B
| $608K | 0.02% |
21,721
-420
| -2% | -$12.1K |
|
|
MSB
303
Mesabi Trust
MSB
$304M
| $607K | 0.02% |
17,150
+300
| +2% | +$10.8K |
|
|
NVTA
304
DELISTED
Invitae Corporation
NVTA
| $607K | 0.02% |
18,000
-2,700
| -13% | -$87.8K |
|
305
Oneok
OKE
$58.7B
| $606K | 0.02% |
10,941
+175
| +2% | +$9.32K |
|
|
MGF
306
Aberdeen Government Markets Income Fund
MGF
$92.2M
| $605K | 0.02% |
136,000
+70,000
| +106% | +$306K |
|
307
Schwab International Equity ETF
SCHF
$69.4B
| $597K | 0.02% |
30,224
+418
| +1% | +$8.26K |
|
308
Unilever
UL
$135B
| $596K | 0.02% |
9,061
| – | – |
|
309
Baxter International
BAX
$14B
| $580K | 0.02% |
7,211
+500
| +7% | +$41.9K |
|
310
iShares Russell 1000 ETF
IWB
$50.5B
| $567K | 0.02% |
2,341
-140
| -6% | -$33K |
|
311
Ford
F
$55.3B
| $562K | 0.02% |
37,790
+11,379
| +43% | +$151K |
|
312
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $561K | 0.02% |
7,654
+4,505
| +143% | +$330K |
|
313
Schwab U.S Small- Cap ETF
SCHA
$23.5B
| $559K | 0.02% |
21,472
-264
| -1% | -$6.75K |
|
314
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
| $556K | 0.02% |
20,380
-1,864
| -8% | -$50.6K |
|
315
Moderna
MRNA
$25.1B
| $552K | 0.02% |
2,350
-650
| -22% | -$116K |
|
316
Labcorp
LH
$26.2B
| $550K | 0.02% |
2,322
-134
| -5% | -$30.5K |
|
317
S&P Global
SPGI
$124B
| $546K | 0.02% |
1,330
+21
| +2% | +$8.07K |
|
318
Skyworks Solutions
SWKS
$10.6B
| $545K | 0.02% |
2,842
| – | – |
|
319
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
| $541K | 0.02% |
20,068
+618
| +3% | +$16.1K |
|
320
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| $523K | 0.02% |
3,893
+251
| +7% | +$33.1K |
|
321
Oracle
ORCL
$449B
| $522K | 0.02% |
6,703
+1,390
| +26% | +$109K |
|
322
Linde
LIN
$220B
| $518K | 0.02% |
1,793
-29
| -2% | -$8.46K |
|
|
MMP
323
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $482K | 0.02% |
9,854
+4,354
| +79% | +$211K |
|
324
Netflix
NFLX
$323B
| $481K | 0.02% |
9,110
-240
| -3% | -$12.3K |
|
325
Yum! Brands
YUM
$41.4B
| $481K | 0.02% |
4,182
-20
| -0.5% | -$2.36K |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
O
Carnegie Investment Counsel's Q2 2021 Portfolio in Review
As of Q2 2021, Carnegie Investment Counsel held 487 positions worth $2.65B, up 11% from $2.39B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Carnegie Investment Counsel deployed $82.9M of net new capital in Q2 2021, opening 33 new positions and adding to 237 existing holdings. Its largest new stake was Mudrick Capital Acquisition Corporation II Class A Common Stock: 792,400 shares worth $9.87M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco BulletShares 2021 Corporate Bond ETF, an estimated $7.42M trimmed.
- Carnegie Investment Counsel's largest Q2 2021 buy was Mudrick Capital Acquisition Corporation II Class A Common Stock: 792,400 shares worth $9.87M.
- Carnegie Investment Counsel added most to Array Technologies in Q2 2021, an estimated $5.42M increase.
- Carnegie Investment Counsel's biggest Q2 2021 reduction was Invesco BulletShares 2021 Corporate Bond ETF, cutting an estimated $7.42M.
- Carnegie Investment Counsel fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $2.99M.
- Carnegie Investment Counsel's ten largest holdings make up 21% of its $2.65B portfolio in Q2 2021.
- Carnegie Investment Counsel opened 33 new positions and closed 15 in Q2 2021.
- Carnegie Investment Counsel's portfolio value rose 11% quarter-over-quarter to $2.65B.
Based on Carnegie Investment Counsel's 13F filing for Q2 2021, filed 16 Jul 2021.